CD4 and neoplasm: Further research is needed to reveal the anti-tumor mechanisms driven by IL-12 and IFN-γ in the 4T1 tumor model, and the activated DCs, NK, CD4+ and CD8+ T cells, as well as immunosuppressive cells in the TME.